TheEdgeResearch
Home / Stocks / PZOO

Pazoo, Inc. (PZOO)

OTC Healthcare Medical - Diagnostics & Research
$0.00 ▲ +0.00%
Market Cap
$26,882
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Beta
6.79
52-Wk Range
0.000001-0.00001
CEO
Steven Basloe
Country
US
Currency
USD

Pazoo, Inc. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in East Hanover, NJ, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $26,882. On trailing twelve-month figures it carries a trailing P/E of -0.00, a net margin of 0.0%. Its beta of 6.79 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.00
Price / Sales
0.00
Price / Book
-0.00
EV / EBITDA
-1.55
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
-0.28
Current ratio
0.01
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
3
IPO date
2012-06-27
Headquarters
East Hanover, NJ, US
About Pazoo, Inc.

Pazoo, Inc. operates as a health and wellness company. It offers laboratory testing services for marijuana. Pazoo, Inc. was formerly known as IUCSS, Inc. and changed its name to Pazoo, Inc. in May 2011. The company was incorporated in 2010 and is headquartered in East Hanover, New Jersey.

Comparable companies

Pazoo, Inc. is most often compared with the following Healthcare names:

CWWBFFFNTFGSACHMPQINSOPEMTFRLBDSHWZVDRMVIVXF
More research on PZOO
PZOO technical analysis PZOO TheEdge Score Compare against peers
Open full interactive analysis & DCF →